Cytori Therapeutics Inc Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 8 of 8 Posts
Plus Therapeutics, Inc. Announces Nasdaq Ticker Symbol Changes And Reverse Stock Split
Article By: NASDAQ GlobeNewswire Tuesday, July 30, 2019 12:16 AM EDT
Plus Therapeutics, Inc. today announced that the Company has officially changed its name from “Cytori Therapeutics, Inc.” to “Plus Therapeutics, Inc.” and the ticker symbol will change from “CYTX” to “PSTV”.
In this article: PSTV
Read
Premarket Biotech Digest – AVGR Announces Positive Data, CXRX To Be Investigated
Article By: KKD Healthcare Analytics Thursday, June 1, 2017 8:26 AM EDT
Microbot Medical Inc. (MBOT) announced receiving a new patent from the Canadian Intellectual Property Office. Avinger (AVGR) stock soared as the company announced the positive 24 month data from the VISION study.
In this article: PSTV Also: APHB, JAZZ, NSTG, AVGR, CXRX, MBOT
Read
Cytori Announces Proposed Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire Monday, April 10, 2017 6:53 PM EDT
Cytori Therapeutics, Inc. announced today that it intends to offer and sell shares of its common stock in an underwritten public offering. All of the shares to be sold in the offering are to be sold by Cytori.
In this article: PSTV
Read
Cytori Therapeutics Acquires Assets Of Azaya Therapeutics
Article By: KKD Healthcare Analytics Tuesday, January 24, 2017 12:26 PM EDT
Cytori Therapeutics announced the acquisition of certain assets from Azaya Therapeutics, which is a privately held firm.
In this article: PSTV
Read
Celgene Beats On Q1 Earnings, Misses Revenues, Keeps View
Article By: Zacks Investment Research Thursday, April 30, 2015 3:00 PM EDT
Despite income up more than 150% and revenues up 20%, lower GAAP EPS guidance contributes to 4% drop in stock so far Thursday.
In this article: CELG, PSTV, BIIB, CRMD
Read
3 Stocks Getting A Boost From Positive Analyst Ratings
Article By: Bret Jensen Monday, April 13, 2015 5:18 AM EDT
When multiple analysts put price targets way above a stock’s current price, investors should take notice. When multiple analysts do the same thing, but for small cap stocks, investors should take action.
In this article: SQBG, PSTV, INO
Read
Week In Review: ATyr Pharma To Raise $86 Million In IPO
Article By: ChinaBio® Today Saturday, April 11, 2015 4:30 PM EDT
ATyr Pharma company develops Physiocrine-based therapeutics to address rare diseases. Its lead molecule, Resolaris, is currently in a Phase Ib/II trial in adult patients with facioscapulohumeral muscular dystrophy.
In this article: RVX, PSTV
Read
EC Convert Catalysts Into Profits: Sagient Research's Edward Stopke
Article By: The Life Sciences Report Friday, January 23, 2015 5:48 PM EDT
The biotech sector is teeming with companies racing to bring the hot new drug or therapy to the marketplace. Edward Stopke of Sagient Research unveils his list of companies with catalytic moments in the making.
In this article: PSTV, VCEL, ATHX, BLUE, CUR, KITE, NVS, AMGN, JUNO, RNN, MRK, ESALF, RPTP, CLDX, SRPT, PTCT, GILD, RMTI
Read
1 to 8 of 8 Posts